Calpuf Nasal Spray 60 mdi belongs to groups of medications called hypocalcemic agents, primarily indicated for the treatment of postmenopausal osteoporosis in women more than five years postmenopause when alternative therapies are unsuitable. Post-menopausal osteoporosis is a medical condition that causes thinning and weakening of the bones during/after a menopausal period.
Calpuf Nasal Spray 60 mdi contains Calcitonin, a human hormone that prevents bone breakdown and increases bone density (thickness). Thus it helps to treat osteoporosis in postmenopausal women.
Use Calpuf Nasal Spray 60 mdi as prescribed by the doctor. Calpuf Nasal Spray 60 mdi may cause certain side effects such as hypocalcemia, runny nose, nosebleed, sinus pain, application site reactions such as rhinitis (stuffy nose), epistaxis (nose bleeds) and other nasal symptoms, back pain, arthralgia (Joint pain) and headache. Most of these side effects do not require medical attention and gradually resolve over time. However, if these side effects persist longer, please consult your doctor.
Calpuf Nasal Spray 60 mdi is for intranasal use only, do not inject or take it orally. Before using Calpuf Nasal Spray 60 mdi, inform your doctor of all your medical conditions, sensitivities, and all medications you are using. Calpuf Nasal Spray 60 mdi is intended for post-menopausal women; therefore, Calpuf Nasal Spray 60 mdi should not be recommended for other populations. Avoid drinking alcohol because it affects how the body absorbs calcium and vitamin D, which are essential for good bone formation.